Department of Obstetrics and Gynecology, The Texas Children's Health Plan (TCHP) Center for Children and Women, Houston, Texas.
Graceland University School of Nursing, Independence, Missouri.
J Midwifery Womens Health. 2021 Jan;66(1):101-107. doi: 10.1111/jmwh.13202.
Approximately 6% of pregnant women develop gestational diabetes mellitus (GDM), which is a strong risk factor for developing type 2 diabetes mellitus. It is recommended that women with GDM complete a 75-g oral glucose tolerance test (OGTT) 4 to 12 weeks postpartum to screen for type 2 diabetes. A 3-month retrospective chart review in 2 patient-centered medical homes found that postpartum screening for type 2 diabetes was performed in only 39% of eligible women, despite recommendations from the American College of Obstetricians and Gynecologists (ACOG) and the American Diabetes Association. Thus, a quality improvement project was initiated to improve the postpartum type 2 diabetes screening rate.
This quality improvement project involved an education session that described current ACOG recommendations for diabetes screening. The education session included a pretest and posttest that evaluated participants' understanding about development of type 2 diabetes after GDM. A team-based postpartum guideline designed to enable women to complete a 75-g OGTT at the 4-to-12-week postpartum appointment was implemented. A postintervention chart review was conducted to determine the postintervention rate of type 2 diabetes screening.
The mean pretest score for the clinical team was 57%, and the mean posttest score was 99%. Postpartum screening for women with GDM was improved from 39% of women for whom screening was indicated to 77% with the implementation of the team-based guideline.
The quality improvement project results demonstrated that improved understanding of ACOG recommendations combined with the implementation of a team-based guideline significantly improved postpartum screening for type 2 diabetes. Team-based management of care, including education of team members about the rationale for change, may also improve outcomes in other quality improvement projects.
大约有 6%的孕妇会患上妊娠糖尿病(GDM),这是发展为 2 型糖尿病的一个强有力的危险因素。建议患有 GDM 的女性在产后 4 至 12 周完成 75 克口服葡萄糖耐量试验(OGTT),以筛查 2 型糖尿病。在两个以患者为中心的医疗之家进行的为期 3 个月的回顾性图表审查发现,尽管美国妇产科医师学会(ACOG)和美国糖尿病协会(ADA)都有建议,但只有 39%符合条件的女性进行了产后 2 型糖尿病筛查。因此,启动了一项质量改进项目,以提高产后 2 型糖尿病的筛查率。
这个质量改进项目包括一个教育会议,介绍了目前 ACOG 关于糖尿病筛查的建议。该教育会议包括一个前测和后测,评估参与者对 GDM 后发展为 2 型糖尿病的理解。实施了一项基于团队的产后指南,旨在使女性能够在产后 4 至 12 周预约时完成 75 克 OGTT。在干预后进行了图表审查,以确定干预后的 2 型糖尿病筛查率。
临床团队的平均前测得分为 57%,平均后测得分为 99%。通过实施基于团队的指南,对患有 GDM 的女性进行产后筛查的比例从有筛查指征的女性的 39%提高到了 77%。
质量改进项目的结果表明,对 ACOG 建议的理解的提高,加上基于团队的指南的实施,显著改善了产后 2 型糖尿病的筛查。团队式的护理管理,包括向团队成员教育改变的基本原理,也可能会改善其他质量改进项目的结果。